Cannabis Investor Sentiment Softens As Institutional Confidence Wanes, Survey Shows
Portfolio Pulse from Rolando García
The ATB Cannabis Investor Sentiment Survey indicates a shift from bullish to neutral sentiment among cannabis investors, primarily due to delays in uplisting to major U.S. exchanges and rescheduling cannabis to Schedule III. Only 31.8% of investors remain optimistic about the MSO sector, down from 83.3% six months ago. Despite this, some investors see potential for a rebound if these changes occur, with the AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) expected to rise significantly.
September 13, 2024 | 5:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) is expected to rise above $20 if cannabis is rescheduled, a significant increase from its current level of $6.86. This potential rebound is contingent on regulatory changes.
The potential for MSOS to rise significantly is based on investor expectations tied to regulatory changes, specifically the rescheduling of cannabis. The ETF's current low price suggests room for growth if these changes materialize.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80